deoxypyridinoline has been researched along with Osteogenesis Imperfecta in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Callewaert, B; Coucke, PJ; Essawi, OH; Essawi, T; Eyre, DR; Gistelinck C, C; Malfait, F; Symoens, S; Tapaneeyaphan, P | 1 |
| Alharbi, M; Finidori, G; Gaubicher, S; Guillou, F; Le Merrer, M; Pinto, G; Polak, M; Souberbielle, JC | 1 |
| Aström, E; Eksborg, S; Magnusson, P; Söderhäll, S | 1 |
| Adami, S; Braga, V; Colapietro, F; Fracassi, E; Gatti, D; Rossini, M; Tatò, L | 1 |
| DiMeglio, LA; Ford, L; McClintock, C; Peacock, M | 1 |
| Eanes, ED; Eyre, DR; Mörike, M; Vetter, U; Weis, MA | 1 |
| Bank, RA; Janus, GJ; Pruijs, HE; Sakkers, RJ; Tekoppele, JM; Van der Sluijs, HA; Wassen, MH | 1 |
| Kawai, S; Sugiyama, T | 1 |
| Clark, SH; Gronowicz, G; Kalajzic, I; Ledgard, F; Mack, K; Naprta, A; Rowe, DW; Rumboldt, Z; Terzic, J | 1 |
2 trial(s) available for deoxypyridinoline and Osteogenesis Imperfecta
| Article | Year |
|---|---|
Intravenous neridronate in adults with osteogenesis imperfecta.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Collagen; Collagen Type I; Diphosphonates; Female; Fractures, Bone; Humans; Infusions, Intravenous; Male; Middle Aged; Osteogenesis Imperfecta; Peptides | 2003 |
Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
Topics: Alkaline Phosphatase; Amino Acids; Anti-Inflammatory Agents; Bone Density; Calcium; Child, Preschool; Collagen; Creatine; Diphosphonates; Female; Fever; Fractures, Bone; Humans; Infant; Infusions, Intravenous; Male; Osteogenesis Imperfecta; Pamidronate; Prospective Studies; Treatment Outcome | 2004 |
7 other study(ies) available for deoxypyridinoline and Osteogenesis Imperfecta
| Article | Year |
|---|---|
New insights on the clinical variability of FKBP10 mutations.
Topics: Adolescent; Adult; Amino Acids; Arthrogryposis; Cells, Cultured; Child; Female; Homozygote; Humans; Male; Mutation; Osteogenesis Imperfecta; Pedigree; Phenotype; RNA Splice Sites; Tacrolimus Binding Proteins | 2020 |
Pamidronate treatment of children with moderate-to-severe osteogenesis imperfecta: a note of caution.
Topics: Absorptiometry, Photon; Amino Acids; Bone Density; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Fracture Healing; Fractures, Bone; Humans; Infusions, Intravenous; Male; Osteocalcin; Osteogenesis Imperfecta; Pamidronate; Parathyroid Hormone; Prospective Studies | 2009 |
Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Density Conservation Agents; Child; Child, Preschool; Cross-Sectional Studies; Diphosphonates; Fractures, Compression; Humans; Injections, Intravenous; Longitudinal Studies; Osteogenesis Imperfecta; Pamidronate; Spinal Fractures; Treatment Outcome | 2010 |
Collagen crosslinks and mineral crystallinity in bone of patients with osteogenesis imperfecta.
Topics: Adolescent; Amino Acids; Bone and Bones; Child; Child, Preschool; Chromatography, High Pressure Liquid; Collagen; Cross-Linking Reagents; Femur; Humans; Infant; Osteogenesis Imperfecta; Regression Analysis; X-Ray Diffraction | 1993 |
Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing.
Topics: Adolescent; Adult; Amino Acids; Arginine; Biomarkers; Biopsy; Bone and Bones; Child; Child, Preschool; Collagen; Humans; Hydroxylysine; Infant; Lysine; Osteogenesis Imperfecta; Pepsin A; Pyridinium Compounds; Reference Values | 2000 |
Changes in bone biochemical markers after high-dose cerivastatin treatment in a woman with osteogenesis imperfecta.
Topics: Administration, Oral; Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Cholesterol; Cholesterol, LDL; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Osteogenesis Imperfecta; Pilot Projects; Prospective Studies; Pyridines; Time Factors | 2001 |
Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.
Topics: Amino Acids; Animals; Biomarkers; Bone and Bones; Bone Development; Bone Matrix; Chloramphenicol O-Acetyltransferase; Collagen Type I; Fluorescent Antibody Technique; Gene Expression Regulation, Developmental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Osteoblasts; Osteogenesis Imperfecta; Promoter Regions, Genetic; RNA, Messenger; Tibia | 2002 |